We hereby announce the meeting organized by the Dutch Society of Toxicology Section Pharmaceutical Toxicology and Section Risk Assessment
TUESDAY APRIL 5, 2022
With an option for digital attendance.
Leiden University Gorlaeus Lecture Hall C1, Address: Einsteinweg 57, Leiden
One substance – Multiple assessments
Titanium Dioxide considered from a food and pharma perspective
In this spring meeting of the NVT, the section Pharmaceutical Toxicology and the section Risk Assessment will give an overview of the challenges from various legal frameworks with regard to the principle of ‘one substance - one assessment’. In support of the EU chemicals strategy for sustainability, the EU Commission is moving towards ‘one substance – one assessment’ principle. But how does this work across different regulatory frameworks? What are the differences in risk assessments and how might end-use of products be impacted? Should one regulate based on hazard or based on risk? Based on an example substance, titanium dioxide, regulatory and risk assessment considerations regarding ‘one substance – one assessment’ will be highlighted.
During the symposium there will be sufficient time to discuss and ask questions to the speakers and other attendees. We hope it will be an inspiring, thought-provoking, and informative meeting.
• Deadline: 29th March
• Email to: Wianda Goense (email@example.com), with subject “Registration NVT spring symposium – 5 April”
• Please indicate: Name and affiliation, and whether you want to attend live or online
If you want to attend online, you will receive the link to the session a few days before.
After the symposium you will be invited to fill in an evaluation form, through which you can request an attendance certificate.
|13:00 – 13.45||Business Meeting (only for members of the NVT section Pharmaceutical Toxicology)|
|13:45 – 14.00||Registration, coffee and tea|
|14.00 – 14.10||Welcome & Instructions|
Day chairman: Susan Dekkers, TNO
|14:10 – 13.40||Introduction: one substance – one assessment|
To be determined, RIVM representative
|14.40 – 15:10||Titanium Dioxide: regulatory and risk assessment aspects from a food perspective|
Jacqueline Castenmiller, NVWA
|15:10 – 15:30||Break|
|15:30 – 16:00||Titanium Dioxide: regulatory and risk assessment aspects, and its implications from a pharma perspective|
Kim Notenboom and Ira Koval, CBG
|16:00 – 16:30||Titanium Dioxide: Communication to patients|
To be determined, KNMP
|16:30 – 16:50|
16:50 – 17:30
|Discussion & wrap-up|
Social get together and drinks
 Taking into account the general corona rules for meetings that apply at that time, a physical meeting might not or only partially possible. In that case, the organizers decide to make it a fully virtual or hybrid meeting. You will be informed about it timely.